Les perturbateurs endocriniens dans les produits cosmétiques commercialisé en Algérie
Loading...
Date
Journal Title
Journal ISSN
Volume Title
Publisher
Université Sétif1 Ferhat Abbas. Faculté de Médecine.
Abstract
Introduction: In ALGÉRIA, the cosmetics market is constantly evolving, the massive use of
this latter whatever their origin (local or imported) and the absence of a clear and explicit
regulation on endocrine disruptors EDs in these products. is likely to be a big problem for the
health of consumers. The main objective of this work is to pull the alarm bells on endocrine
disruptors in cosmetics market in ALGÉRIA; by controlling the presence of EDs in their
composition.
Material and Methods: We conducted a cross-sectional observational study, to analyze the
composition of cosmetic products marketed in ALGÉRIA and the presence of qualified
ingredients endocrine disruptors, received at the toxicology service - CHU Saadna Abdennour -
SETIF for analysis toxicological.
Results: the cosmetic products analyzed were 49 of different types distributed over three
categories, of local origin or import, with a statistically significant predominance for the
aqueous forms.
63% of the products analyzed contain at least one ED. The daily use of a mixture of cosmetic
products containing the same disturbing substance can contribute to an accumulation of effect
which has a very negative impact on consumer’s health.
A concern about the combination and concomitant exposure of proven or suspected endocrine
disruptors whose mechanism of action is similar and the effect is synergistic as is the case with
Paraben, Phenoxyethanol, Cyclomethicone PVP found in the same product which explains the
cocktail effect. In ALGÉRIA, cosmetic products are not submitted to a strict regulation.
Conclusion: a rigorous regulation is indispensable to face the anarchic use of disruptive
substances to perform different function without considering the toxic risk. The creation of
a cosmetovigilance center is of paramount necessity due its essential role which allows the
declaration of undesirable effects by health professionals and consumers, as well as the
collection of information relating to these effects with a preventive aim.
